Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2022. “We closed the year with a strong fourth quarter and demonstrated operating discipline in a dynamic environment while providing patient-centered high quality care,” said Saum Sutaria, M.D., Chief Executive Officer of Tenet. “Our momentum going into 2023 positions us for continued growth as we remain focused on expanding our industry-leading ambulatory bu

USPI and Providence Expand Partnership with a New Development Agreement

DALLAS–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory surgery platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and Providence, a not-for-profit health system serving the Western U.S., announced today that they have signed a new development agreement that will increase access to ambulatory surgical services across many communities. USPI and Providence entered a joint venture partnership in 2004 in California, which has grown to fi

USPI and Providence Expand Partnership with a New Development Agreement

DALLAS–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory surgery platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and Providence, a not-for-profit health system serving the Western U.S., announced today that they have signed a new development agreement that will increase access to ambulatory surgical services across many communities. USPI and Providence entered a joint venture partnership in 2004 in California, which has grown to fi

Brightseed Preclinical Data Shows Potential for Bioactive Compounds to Support Gut Barrier Function

SAN FRANCISCO–(BUSINESS WIRE)–Brightseed, the bioactives company, today announced preclinical data in the peer-reviewed Journal of Food Bioactives showing that two bioactive compounds found in hemp hulls, N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT), have potential to support gut barrier function.1 Gut health has been shown to be central to the body’s overall health, impacting the immune system and the gut-brain axis. The gut barrier plays a key role in maintaining overal

Brightseed Preclinical Data Shows Potential for Bioactive Compounds to Support Gut Barrier Function

SAN FRANCISCO–(BUSINESS WIRE)–Brightseed, the bioactives company, today announced preclinical data in the peer-reviewed Journal of Food Bioactives showing that two bioactive compounds found in hemp hulls, N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT), have potential to support gut barrier function.1 Gut health has been shown to be central to the body’s overall health, impacting the immune system and the gut-brain axis. The gut barrier plays a key role in maintaining overal